In a recent article appearing on, Emord & Associates’ associate Bethany R. Kennedy comments on new dietary ingredient notifications for products that are approved drugs outside of the U.S.  Click below to read the full text of the article at

Hank Schultz, “Companies must walk fine line when bringing a supplement to market in US that is a drug elsewhere,”  (Mar. 27, 2014).


Share →

Leave a Reply